Main content
Comment on: Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Contributors:
Date created: | Last Updated:
: DOI | ARK
Creating DOI. Please wait...
Category: Project
OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
Accept